麥迪科技(603990.SH)股東嚴黃紅減持期過半 集中競價減持112.44萬股
格隆匯4月22日丨麥迪科技(603990.SH)公佈,截止本次減持計劃實施之前,公司股東嚴黃紅持有公司股份1079.4萬股,佔公司股本總數的9.5985%,嚴黃紅系公司控股股東翁康的一致行動人,本次減持不會導致上市公司控制權發生變更。
公司於2020年1月2日披露了《蘇州麥迪斯頓醫療科技股份有限公司股東減持股份計劃公告》,嚴黃紅計劃於2020年1月23日至2020年7月21日期間通過集中競價交易方式減持公司股份不超過224.91萬股。截止本公告披露日,嚴黃紅減持時間已過半,嚴黃紅通過集中競價交易方式減持了112.44萬股公司的股份,佔公司總股本的0.9999%。本次減持計劃尚未實施完畢。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.